Advertisement Chemaphor launches specialty chemicals business - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Chemaphor launches specialty chemicals business

Chemaphor, a Canadian biotechnology R&D company, has launched its specialty chemicals business.

Chemaphor said that it has core expertise in organic chemistry and as a secondary activity, specializes in the synthesis of research chemicals labeled with stable isotopes.

The use of carefully selected and tested synthetic techniques yields deuterated compounds of high purity (99%) and high levels of enrichment (99%). Deuterated products in stock include vitamin D and its hydroxy metabolites, cholesterol and its hydroxy metabolite, and vitamin E (alpha-tocopherol).

Isotopically labeled chemicals are valuable research tools with many applications. They can be used as internal standards for analytical chemistry, and they are especially useful in the study of the metabolism of their non-labeled counterparts, said Chemaphor.